| 摘要 |
The present invention provides improved methods for treating inflammatory bowel disease in all of its forms. The present invention is based, in part, on the surprising discovery that treatment with angiotensin peptide significantly improves several of the symptoms observed in a mouse model of inflammatory bowel disease including weight loss and disease activity index. This is particularly unexpected due to the suggestions that ACE-2 inhibitors are of utility in treating these diseases. The beneficial use of ACE2 inhibitors in treating inflammatory conditions would lead one to believe that they would not be of benefit, or may even be harmful in such a condition. |
